Depo-provera and Levothroid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Depo-provera (medroxyprogesterone acetate) and Levothroid (levothyroxine sodium). Common drug interactions include hyperkinetic syndrome among females and abdominal adhesions among males.

The phase IV clinical study analyzes what interactions people have when they take Depo-provera and Levothroid. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Depo-provera?

Depo-provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 17,093 Depo-provera users. Check the latest studies of Depo-provera.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.



On Jul, 20, 2026

13 people who take Depo-provera and Levothroid together, and have interactions are studied.

Depo-provera and Levothroid drug interactions.

What are the common drug interactions of Depo-Provera and Levothroid, by gender? *:

female:

  1. Hyperkinetic syndrome (attention deficit disorder)
  2. Hypersensitivity
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Impaired gastric emptying
  5. Insomnia (sleeplessness)
  6. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  7. Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)
  8. Lordosis (outward curve of the back bone)
  9. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  10. Mania (a state of abnormally elevated or irritable mood)

male:

  1. Abdominal adhesions (inflammation of abdomen)
  2. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  3. Attention deficit/hyperactivity disorder
  4. Autonomic failure syndrome (a degenerative disease of the autonomic nervous system)
  5. Autonomic neuropathy (malfunction of the autonomic nervous system (ans))
  6. Blood glucose fluctuation
  7. Cardiolipin antibody positive
  8. Cerebellar ataxia (loss of coordination)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Depo-Provera and Levothroid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  2. Depression
  3. Migraine (headache)
  4. Ovarian cyst ruptured (tear in fluid filled sac of the ovary)
  5. Ovarian torsion (twisting of ovary)
  6. Polycystic ovaries (cysts in the ovaries that occurs when the follicle stops developing)

30-39:

  1. Blood cholesterol increased
  2. Type 2 diabetes mellitus

40-49:

  1. Drug eruption (adverse drug reaction of the skin)
  2. Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)
  3. Oral soft tissue disorder (oral soft tissue disease)
  4. Rash generalised (rash on most of body parts)
  5. Skin lesion
  6. Swelling face
  7. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

  1. Fall
  2. Mydriasis (a dilation of the pupil)
  3. Depression
  4. Dyspnoea (difficult or laboured respiration)
  5. Swelling face

60+:

  1. Abdominal adhesions (inflammation of abdomen)
  2. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  3. Attention deficit/hyperactivity disorder
  4. Autonomic failure syndrome (a degenerative disease of the autonomic nervous system)
  5. Autonomic neuropathy (malfunction of the autonomic nervous system (ans))
  6. Blood glucose fluctuation
  7. Breast cancer
  8. Cardiolipin antibody positive
  9. Cerebellar ataxia (loss of coordination)
  10. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

What are the existing conditions these people have? *

  1. Neuropathy Peripheral (surface nerve damage): 2 people, 15.38%
  2. Impaired Gastric Emptying: 2 people, 15.38%
  3. High Blood Pressure: 2 people, 15.38%
  4. Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 2 people, 15.38%
  5. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 15.38%
  6. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 7.69%
  7. Pain: 1 person, 7.69%
  8. Menopausal Symptoms: 1 person, 7.69%
  9. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 7.69%
  10. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Depo-provera and Levothroid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Depo-provera and Levothroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Depo-provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levothroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Depo-provera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on medroxyprogesterone acetate and levothyroxine sodium (the active ingredients of Depo-provera and Levothroid, respectively), and Depo-provera and Levothroid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: